Implants and Other Types of Augmentation

Breast MRI for implant assessment evaluates implant integrity, complications, and the surrounding breast tissue.

Key Principles

  • Implant assessment MRI does not require contrast — no BI-RADS assessment is given for non-contrast implant-only exams
  • Silicone-specific sequences suppress both water and fat so only silicone appears bright
  • T2-weighted images assess peri-implant fluid
  • Bilateral imaging should be performed

Implant Descriptors

1. Location

DescriptorDefinition
Implant — PrepectoralAnterior to pectoralis major
Implant — RetropectoralDeep to pectoralis major

2. Material and Integrity

MaterialKey Features
Implant Material — SalineWater signal on all sequences; filling valve characteristic; rupture is clinically evident
Implant Material — SiliconeBright on silicone-specific sequences; rupture may be “silent”
OtherAutologous flaps (TRAM, DIEP, latissimus), direct injection (silicone, paraffin)

3. Lumen Type

  • Single — most common
  • Double — inner/outer lumens (silicone/saline or silicone/silicone); can mimic intracapsular rupture

4. Intracapsular Silicone Findings

FindingSignificance
Implant — Radial FoldsNormal variant — infolding of intact shell
Implant — Subcapsular Line SignIntracapsular rupture
Implant — Keyhole SignIntracapsular rupture
Implant — Linguine SignIntracapsular rupture (collapsed shell)
Implant — Water DropletsCan occur in intact OR ruptured implants

5. Extracapsular Silicone

LocationSignificance
BreastCurrent or prior extracapsular rupture
Lymph nodesRupture or “silicone bleed” from intact implants

6. Other Implant Findings

  • Focal contour bulge — intact implant distortion from capsular contraction
  • Peri-implant fluid — trace is normal; >trace suspicious for infection, seroma, or BIA-ALCL

Board Pearl

BIA-ALCL (breast implant-associated anaplastic large cell lymphoma) presents with delayed peri-implant effusion (>1 year after placement). A persistent delayed effusion should prompt fine-needle aspiration to evaluate for BIA-ALCL. Ultrasound is the primary modality to further assess suspicious peri-implant fluid.

FDA Recommendations

  • Asymptomatic silicone implant patients: imaging (US or MRI) 5–6 years after placement, then every 2–3 years for “silent rupture”